摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N(1-carbamoyl-1-oxo-3-phenyl-propan-2-yl)-2(4(piperidin-1-yl-methyl)-phenyl)-benzamide | 1139224-79-5

中文名称
——
中文别名
——
英文名称
N(1-carbamoyl-1-oxo-3-phenyl-propan-2-yl)-2(4(piperidin-1-yl-methyl)-phenyl)-benzamide
英文别名
N-(4-amino-3,4-dioxo-1-phenylbutan-2-yl)-2-[4-(piperidin-1-ylmethyl)phenyl]benzamide
N(1-carbamoyl-1-oxo-3-phenyl-propan-2-yl)-2(4(piperidin-1-yl-methyl)-phenyl)-benzamide化学式
CAS
1139224-79-5
化学式
C29H31N3O3
mdl
——
分子量
469.583
InChiKey
ALFFYYGVDIMISS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    35
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    92.5
  • 氢给体数:
    2
  • 氢受体数:
    4

文献信息

  • Novel substituted amides, their preparation and use
    申请人:Abbott GmbH & Co., KG
    公开号:US20040082569A1
    公开(公告)日:2004-04-29
    An amide of the formula I 1 and its tautomeric forms, possible enantiomeric and diastereomeric forms, E and Z forms, and possible physiologically tolerated salts, in which the variables have the following meanings: A —(CH 2 ) p —R 1 , where R 1 can be pyrrolidine [sic], morpholine [sic], piperidine [sic], —NR 5 R 6 and 2 and R 5 , R 6 and R 7 can, independently of one another, be hydrogen, C 1 -C 4 -alkyl, CH 2 Ph, Ph, CH 2 CH 2 Ph, it also being possible for the phenyl rings to be substituted by R 6 , and p can be 1 and 2, and B can be phenyl [sic], pyridyl [sic], pyrimidyl [sic] and pyridazyl [sic], it also being possible for the rings to be substituted by up to 2 R 8 radicals, and D can be a bond, —(CH 2 ) m —, —CH═CH—, —C≡C—, and R 2 is chlorine, bromine, fluorine, C 1 -C 6 -alkyl, NHCO—C 1 -C 4 -alkyl, NHSO 2 —C 1 -C 4 -alkyl, NO 2 , —O—C 1 -C 4 -alkyl and NH 2 , and R 3 is —C 1 -C 6 -alkyl, branched or unbranched, and which may also carry a phenyl ring, indolyl ring or cyclohexyl ring which is in turn substituted by by [sic] a maximum of two R 8 radicals, where R 8 is hydrogen, C 1 -C 4 -alkyl, branched or unbranched, —O—C 1 -C 4 -alkyl, OH, Cl, F, Br, I, CF 3 , NO 2 , NH 2 , CN, COOH, COO—C 1 -C 4 -alkyl, NHCO—C 1 -C 4 -alkyl, —NHSO 2 -C 1 C 4 -alkyl and —SO 2 —C 1 -C 4 -alkyl; and Y is phenyl [sic], pyridine, pyrimidine and pyrazine and R 4 is hydrogen, COOR 9 and CO-Z in which Z is NR 10 R 11 and 3 R 9 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and R 10 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which itself may also be substituted by one or two R 12 radicals, and 4 R 11 is hydrogen, C 1 -C 6 -alkyl, branched or unbranched, which may also be and [sic] substituted by a phenyl ring which may also carry an R 9 radical, and R 12 can be hydrogen, C 1 -C 4 -alkyl, branched or unbranched, —O—C 1 -C 4 -alkyl, OH, Cl, F, Br, I, CF 3 , NO 2 , NH 2 , CN, COOH, COO—C 1 -C 4 -alkyl, —NHCO—C 1 -C 4 -alkyl, —NHCO-phenyl, —NHSO 2 —C 1 -C 4 -alkyl, NHSO 2 -phenyl, —SO 2 —C 1 -C 4 -alkyl and —SO 2 -phenyl, R 13 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and R 14 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and n is a number 0, 1 or 2, and m,q are, independently of one another, a number 0, 1, 2, 3 or 4.
    公式I1的酰胺及其互变异构体、可能的对映异构体和顺反异构体、E和Z形式,以及可能的生理耐受盐,其中变量具有以下含义:A -(CH2)p-R1,其中R1可以是吡咯烷、吗啉、哌啶、-NR5R6和2,而R5、R6和R7可以独立地是氢、C1-C4-烷基、 Ph、Ph、 Ph,苯环也可以被R6取代,p可以是1和2,B可以是苯、吡啶嘧啶吡嗪,环也可以被最多2个R8基团取代,D可以是键、( )m、CH=CH、C≡C,R2是、C1-C6-烷基、NHCO-C1-C4-烷基、NHSO2-C1-C4-烷基、NO2、O-C1-C4-烷基和NH2,R3是C1-C6-烷基、支链或非支链,也可以携带苯环、吲哚环或环己烷环,该环可以被最多两个R8基团取代,其中R8是氢、C1-C4-烷基、支链或非支链、O-C1-C4-烷基、OH、Cl、F、Br、I、CF3、 、NH2、CN、COOH、COO-C1-C4-烷基、NHCO-C1-C4-烷基、NHSO2-C1C4-烷基和-SO2-C1-C4-烷基;Y是苯、吡啶嘧啶吡嗪,R4是氢、COOR9和CO-Z,其中Z是NR10R11和3,R9是氢、C1-C6-烷基、线性或支链,也可以被一个苯环取代,该苯环本身也可以被一个或两个R12基团取代,R10是氢、C1-C6-烷基、线性或支链,也可以被一个苯环取代,该苯环本身也可以被一个或两个R12基团取代,4R11是氢、C1-C6-烷基、支链或非支链,也可以被一个苯环取代,该苯环也可以携带一个R9基团,R12可以是氢、C1-C4-烷基、支链或非支链、O-C1-C4-烷基、OH、Cl、F、Br、I、 、 、NH2、CN、COOH、COO-C1-C4-烷基、NHCO-C1-C4-烷基、NHCO-苯基、NHSO2-C1-C4-烷基、NHSO2-苯基、SO2-C1-C4-烷基和SO2-苯基,R13是氢、C1-C6-烷基、线性或支链,也可以被一个苯环取代,该苯环本身也可以被一个或两个R12基团取代,R14是氢、C1-C6-烷基、线性或支链,也可以被一个苯环取代,该苯环本身也可以被一个或两个R12基团取代,n是0、1或2,m、q独立地是0、1、2、3或4的数字。
  • NOVEL SUBSTITUTED AMIDES, THEIR PREPARATION AND USE
    申请人:Treiber Hans-Jörg
    公开号:US20110275615A1
    公开(公告)日:2011-11-10
    An amide of the formula I and its tautomeric forms, possible enantiomeric and diastereomeric forms, E and Z forms, and possible physiologically tolerated salts, in which the variables have the following meanings: A —(CH 2 ) p —R 1 , where R 1 can be pyrrolidine, morpholine, piperidine, —NR 5 R 6 and and R 5 , R 6 and R 7 can, independently of one another, be hydrogen, C 1 -C 4 -alkyl, CH 2 Ph, Ph, CH 2 CH 2 Ph, it also being possible for the phenyl rings to be substituted by R 6 , and p can be 1 and 2, and B can be phenyl, pyridyl, pyrimidyl and pyridazyl, it also being possible for the rings to be substituted by up to 2 R 8 radicals, and D can be a bond, —(CH 2 ) m —, —CH═CH—, —C═C—, and R 2 is chlorine, bromine, fluorine, C 1 -C 6 -alkyl, NHCO—C 1 -C 4 -alkyl, NHSO 2 —C 1 -C 4 -alkyl, NO 2 , —O—C 1 -C 4 -alkyl and NH 2 , and R 3 is —C 1 -C 6 -alkyl, branched or unbranched, and which may also carry a phenyl ring, indolyl ring or cyclohexyl ring which is in turn substituted by a maximum of two R 8 radicals, where R 8 is hydrogen, C 1 -C 4 -alkyl, branched or unbranched, —O—C 1 -C 4 -alkyl, OH, Cl, F, Br, I, CF 3 , NO 2 , NH 2 , CN, COOH, COO—C 1 -C 4 -alkyl, NHCO—C 1 -C 4 -alkyl, —NHSO 2 —C 1 -C 4 -alkyl and —SO 2 —C 1 -C 4 -alkyl; and Y is phenyl, pyridine, pyrimidine and pyrazine and R 4 is hydrogen, COOR 9 and CO—Z in which Z is NR 10 R 11 and R 9 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and R 10 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which itself may also be substituted by one or two R 12 radicals, and R 11 is hydrogen, C 1 -C 6 -alkyl, branched or unbranched, which may also be and substituted by a phenyl ring which may also carry an R9 radical, and R 12 can be hydrogen, C 1 -C 4 -alkyl, branched or unbranched, —O—C 1 -C 4 -alkyl, OH, Cl, F, Br, J, CF 3 , NO 2 , NH 2 , CN, COOH, COO—C 1 -C 4 -alkyl, —NHCO—C 1 -C 4 -alkyl, —NHCO-phenyl, —NHSO 2 —C 1 -C 4 -alkyl, NHSO 2 -phenyl, —SO 2 —C 1 -C 4 -alkyl and —SO 2 -phenyl, R 13 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and R 14 is hydrogen, C 1 -C 6 -alkyl, linear or branched, and which may [lacuna] substituted by a phenyl ring which may itself also be substituted by one or two R 12 radicals, and n is a number 0, 1 or 2, and m,q are, independently of one another, a number 0, 1, 2, 3 or 4.
    公式I的酰胺及其互变异构体、可能的对映异构体和顺反异构体、E和Z形式以及可能的生理耐受盐,其中变量具有以下含义: A - (CH2)p-R1,其中R1可以是吡咯烷、吗啉、哌啶、-NR5R6,R5、R6和R7可以独立地是氢、C1-C4烷基、 Ph、Ph、 Ph,苯环还可以被R6取代,p可以是1和2,而B可以是苯、吡啶嘧啶吡嗪,环也可以被多达2个R8基团取代,而D可以是键,- ( )m-,-CH═CH-,-C═C-,而R2是、C1-C6烷基、NHCO-C1-C4烷基、NHSO2-C1-C4烷基、NO2、-O-C1-C4烷基和NH2,而R3是C1-C6烷基,支链或直链,也可能带有苯环、吲哚环或环己基,该环也可能被多达两个R8基团取代,其中R8是氢、C1-C4烷基、支链或直链、-O-C1-C4烷基、OH、Cl、F、Br、I、CF3、 、NH2、CN、COOH、COO-C1-C4烷基、NHCO-C1-C4烷基、-NHSO2-C1-C4烷基和-SO2-C1-C4烷基;而Y是苯、吡啶嘧啶吡嗪,而R4是氢、COOR9和CO-Z,其中Z是NR10R11,而R9是氢、C1-C6烷基、线性或支链,也可能被苯环取代,该苯环本身也可能被一个或两个R12基团取代,而R10是氢、C1-C6烷基、线性或支链,也可能被苯环取代,该苯环本身也可能被一个或两个R12基团取代,而R11是氢、C1-C6烷基、支链或直链,也可能被一个苯环取代,该苯环也可能带有一个R9基团,而R12可以是氢、C1-C4烷基、支链或直链、-O-C1-C4烷基、OH、Cl、F、Br、J、 、 、NH2、CN、COOH、COO-C1-C4烷基、-NHCO-C1-C4烷基、-NHCO-苯基、-NHSO2-C1-C4烷基、NHSO2-苯基、-SO2-C1-C4烷基和-SO2-苯基,而R13是氢、C1-C6烷基、线性或支链,也可能被一个苯环取代,该苯环也可能带有一个或两个R12基团,而R14是氢、C1-C6烷基、线性或支链,也可能被一个苯环取代,该苯环也可能带有一个或两个R12基团,n是0、1或2,而m、q是独立的数字0、1、2、3或4。
  • NEUE SUBSTITUIERTE AMIDE, DEREN HERSTELLUNG UND ANWENDUNG
    申请人:Abbott GmbH & Co. KG
    公开号:EP1073641B1
    公开(公告)日:2004-04-14
  • US6753327B1
    申请人:——
    公开号:US6753327B1
    公开(公告)日:2004-06-22
  • US7276500B2
    申请人:——
    公开号:US7276500B2
    公开(公告)日:2007-10-02
查看更多

同类化合物

(R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 ((3S,4R)-3-氨基-4-羟基哌啶-1-基)(2-(1-(环丙基甲基)-1H-吲哚-2-基)-7-甲氧基-1-甲基-1H-苯并[d]咪唑-5-基)甲酮盐酸盐 高氯酸哌啶 高托品酮肟 马来酸帕罗西汀 颜料红48:4 顺式3-氟哌啶-4-醇盐酸盐 顺式2,6-二甲基哌啶-4-酮 顺式1-苄基-4-甲基-3-甲氨基-哌啶 顺式-叔丁基4-羟基-3-甲基哌啶-1-羧酸酯 顺式-6-甲基-哌啶-1,3-二甲酸1-叔丁酯 顺式-5-(三氟甲基)哌啶-3-羧酸甲酯盐酸盐 顺式-4-叔丁基-2-甲基哌啶 顺式-4-Boc-氨基哌啶-3-甲酸甲酯 顺式-4-(氮杂环丁烷-1-基)-3-氟哌 顺式-3-顺式-4-氨基哌啶 顺式-3-甲氧基-4-氨基哌啶 顺式-3-BOC-3,7-二氮杂双环[4.2.0]辛烷 顺式-3-(1-吡咯烷基)环丁腈 顺式-3,5-哌啶二羧酸 顺式-3,4-二溴-3-甲基吡咯烷盐酸盐 顺式-2,6-二甲基-4-氧代哌啶-1-羧酸叔丁基酯 顺式-1-叔丁氧羰基-4-甲基氨基-3-羟基哌啶 顺式-1-boc-3,4-二氨基哌啶 顺式-1-(4-叔丁基环己基)-4-苯基-4-哌啶腈 顺式-1,3-二甲基-4-乙炔基-6-苯基-3,4-哌啶二醇 顺-4-(4-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-4-(2-氟苯基)-1-(4-异丙基环己基)-4-哌啶羧酸 顺-3-氨基-4-氟哌啶-1-羧酸叔丁酯 顺-1-苄基-4-甲基哌啶-3-氨基酸甲酯盐酸盐 非莫西汀 雷芬那辛 雷拉地尔 阿维巴坦中间体4 阿格列汀杂质 阿尼利定盐酸盐 CII 阿尼利定 阿塔匹酮 阿哌沙班杂质BMS-591455 阿哌沙班杂质87 阿哌沙班杂质52 阿哌沙班杂质51 阿哌沙班杂质5 阿哌沙班杂质 阿哌沙班杂质 阿哌沙班-d3 阿哌沙班 阻聚剂701 间氨基谷氨酰胺